SMTL ID : 9sg0.1

CJM112 Fv in complex with human IL-17A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

hetero-2-2-2-mer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 5 residues within 4Å: Chain A: H.60, K.76 Chain B: F.27, T.28, Y.32 3 PLIP interactions: 2 interactions with chain A, 1 interactions with chain B Salt bridges: A:H.60, A:K.76 Hydrogen bonds: B:T.28 SO4.2: 5 residues within 4Å: Chain D: H.60, K.76 Chain E: F.27, T.28, Y.32 5 PLIP interactions: 3 interactions with chain E, 2 interactions with chain D Hydrogen bonds: E:T.28, E:T.28, E:Y.32 Salt bridges: D:H.60, D:K.76

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ungan, D. et al., IL-17A complexes with therapeutic antibodies exhibit distinct size distributions, potentially contributing to clinically observed immunogenicity. Mabs (2025)

Release Date

2025-10-29

Peptides

Interleukin-17A: AD
CJM112 Fv heavy-chain: BE
CJM112 Fv light-chain: CF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

D
A

B
H

E
H

C
L

F
L

Interleukin-17A

CJM112 Fv heavy-chain

CJM112 Fv light-chain

Related Entries With Identical Sequence